KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Assets Average (2016 - 2025)

Historic Assets Average for Bristol Myers Squibb (BMY) over the last 16 years, with Q3 2025 value amounting to $95.8 billion.

  • Bristol Myers Squibb's Assets Average rose 172.53% to $95.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $95.8 billion, marking a year-over-year increase of 172.53%. This contributed to the annual value of $93.9 billion for FY2024, which is 219.66% down from last year.
  • As of Q3 2025, Bristol Myers Squibb's Assets Average stood at $95.8 billion, which was up 172.53% from $93.6 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Assets Average peaked at $115.5 billion during Q1 2021, and registered a low of $92.4 billion during Q3 2023.
  • Its 5-year average for Assets Average is $99.5 billion, with a median of $96.8 billion in 2024.
  • As far as peak fluctuations go, Bristol Myers Squibb's Assets Average plummeted by 1326.11% in 2021, and later surged by 314.59% in 2024.
  • Bristol Myers Squibb's Assets Average (Quarter) stood at $110.1 billion in 2021, then decreased by 11.44% to $97.5 billion in 2022, then decreased by 4.41% to $93.2 billion in 2023, then dropped by 0.08% to $93.1 billion in 2024, then rose by 2.84% to $95.8 billion in 2025.
  • Its Assets Average stands at $95.8 billion for Q3 2025, versus $93.6 billion for Q2 2025 and $92.5 billion for Q1 2025.